CKD Bio Corp.

CKD Bio Corp.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW1575.18
Market Cap
KRW140.29 B
Shares Outstanding
5.23 M
Public Float
3.18 M

Profile

Address
Chongkundang Building
Seoul SL 03742
Korea, Republic Of
Employees -
Website http://www.ckdbio.com
Updated 07/08/2019
CKD Bio Corp. engages in the manufacture and sale of raw material medicine. Its products include potassium clavulanate, demeclocycline, rifampicin, and acarbose. The company was founded on November 12, 2001 and is headquartered in Seoul, South Korea.

Financials

View All

Jeong-Jin Lee
Chief Executive Officer, Director & Vice President
Jin-Hyo Jung
Director